Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
American Oncology Network Inc. (AONC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: AONC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Above Average Performance
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Analysis of Past Performance
Type Stock | Historic Profit -9.44% | Avg. Invested days 76 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 160.44M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 1380 | Beta 0.52 | 52 Weeks Range 1.01 - 5.98 | Updated Date 04/2/2025 |
52 Weeks Range 1.01 - 5.98 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.89 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 300151685 | Price to Sales(TTM) 0.09 |
Enterprise Value 300151685 | Price to Sales(TTM) 0.09 | ||
Enterprise Value to Revenue 0.17 | Enterprise Value to EBITDA 165.37 | Shares Outstanding 32087700 | Shares Floating 23133012 |
Shares Outstanding 32087700 | Shares Floating 23133012 | ||
Percent Insiders 17.53 | Percent Institutions 0.08 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
American Oncology Network Inc.
Company Overview
History and Background
American Oncology Network (AON) was founded in 2018 to create a community oncology platform that brings advanced cancer care and comprehensive services to local communities. It has grown rapidly through partnerships with independent oncology practices.
Core Business Areas
- Physician Partnership: AON partners with independent oncology practices, providing them with resources and support to enhance patient care and practice management.
- Comprehensive Services: AON offers a range of services, including oncology care, hematology, radiation therapy, chemotherapy, immunotherapy, and patient support services.
- Technology and Infrastructure: AON provides its partner practices with technology and infrastructure solutions to improve efficiency and enhance patient outcomes.
Leadership and Structure
AON is led by a team of experienced healthcare executives and physicians. The organizational structure is centered around supporting and integrating independent oncology practices.
Top Products and Market Share
Key Offerings
- Oncology Care Services: Comprehensive cancer treatment and support services provided through its network of affiliated practices. Market share data is not publicly available. Competitors include large hospital systems and other oncology networks.
- Practice Management Services: Administrative, technological, and operational support provided to partner practices. Market share data is not publicly available. Competitors include McKesson, Cardinal Health, and other healthcare consulting firms.
Market Dynamics
Industry Overview
The oncology market is experiencing growth due to aging populations and advancements in cancer treatment. The trend is toward integrated care models and value-based care.
Positioning
AON aims to be a leading provider of community oncology services by partnering with independent practices and offering comprehensive care solutions. Its competitive advantage lies in its ability to preserve the independence of community practices while providing access to advanced resources.
Total Addressable Market (TAM)
The US cancer care market is estimated at hundreds of billions of dollars annually. AON is positioned to capture a share of this market through its network of affiliated practices.
Upturn SWOT Analysis
Strengths
- Strong network of affiliated oncology practices
- Comprehensive service offerings
- Experienced leadership team
- Focus on community oncology
Weaknesses
- Reliance on partnerships with independent practices
- Limited brand recognition compared to larger hospital systems
- Potential for integration challenges with partner practices
Opportunities
- Expansion into new geographic markets
- Development of new oncology care services
- Increased adoption of value-based care models
- Acquisition of additional oncology practices
Threats
- Increased competition from larger healthcare providers
- Changes in healthcare regulations
- Rising costs of cancer treatment
- Consolidation of independent oncology practices
Competitors and Market Share
Key Competitors
- US Oncology (McKesson)
- Cardinal Health Specialty Solutions
- OneOncology
Competitive Landscape
AON differentiates itself through its focus on partnering with and supporting independent oncology practices, allowing them to maintain their autonomy while benefiting from the resources of a larger organization. The large competitors are McKesson, Cardinal Health, and OneOncology. AON will need to compete on services.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: AON has experienced rapid growth in recent years through the addition of new partner practices.
Future Projections: Future growth is expected to be driven by continued expansion into new markets and the addition of new oncology care services. Analyst estimates are unavailable since AON is a private company.
Recent Initiatives: AON has focused on expanding its network of affiliated practices and investing in technology and infrastructure to support its partner practices.
Summary
American Oncology Network is a rapidly growing company with a focus on community oncology. Its strength lies in partnering with independent practices and providing comprehensive services. It needs to navigate the competitive landscape and integration challenges to achieve sustained growth. Its lack of financial disclosure limits a thorough analysis.
Similar Companies
CAH
Cardinal Health Inc
CAH
Cardinal Health Inc
MCK
McKesson Corporation
MCK
McKesson Corporation
Sources and Disclaimers
Data Sources:
- American Oncology Network Website
- Company Press Releases
- Industry Reports
- Third party market reports and news sources.
Disclaimers:
Financial information is based on limited publicly available data. Market share estimates are based on industry reports and expert analysis. This analysis is for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc.
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-05 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.